Effect of ruboxistaurin on the visual acuity decline associated with long-standing diabetic macular edema

Investigative Ophthalmology & Visual Science
Matthew D DavisPKC-DRS2 Study Group

Abstract

To compare relationships between severity and duration of diabetic macular edema (DME) and visual acuity (VA) observed in the PKC-DRS2 with those from the Early Treatment Diabetic Retinopathy Study (ETDRS) and to assess the effect of the orally administered PKC beta inhibitor ruboxistaurin (RBX) on these parameters. In the PKC-DRS2, patients with moderately severe to very severe nonproliferative diabetic retinopathy (n = 685) were randomly assigned to 32 mg/d RBX or placebo and followed up for 36 months with ETDRS VA measurements and fundus photographs (FP) every 3 to 6 months. Mean VA was calculated across all FP visits for eyes in each level of the ETDRS DME severity scale at those visits. For eyes with baseline VA > or = 20/40, relationships between change in VA from baseline to last visit and duration of severe DME were analyzed with linear regression. Mean VA decreased by approximately 22 letters between the mildest and most severe levels of the DME scale in the PKC-DRS2, compared with 27 letters in the ETDRS. In the placebo group, the rate of decrease in VA over time associated with duration of severe DME was 0.67 letters per month (24 letters over 36 months, compared with 20 letters over 28-36 months in the ETDRS). This ...Continue Reading

Citations

Jun 1, 2011·Journal of Ocular Biology, Diseases, and Informatics·Jan J BlomWilliam D Eldred
Jun 8, 2012·Cold Spring Harbor Perspectives in Medicine·Motasem Al-LatayfehLloyd Paul Aiello
Jan 3, 2013·The Journal of Clinical Investigation·Jop H van BerloJeffery D Molkentin
Feb 1, 2011·Therapeutic Advances in Endocrinology and Metabolism·Chirag P Shah, Carolyn Chen
Apr 27, 2013·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Mohd Imtiaz NawazMohammad Shamsul Ola
Dec 18, 2013·Middle East African Journal of Ophthalmology·Ahmed M Abu El-Asrar
Jan 10, 2012·Journal of Diabetes and Its Complications·Mohammad Shamsul OlaAhmed M Abu El-Asrar
Jun 24, 2011·Journal français d'ophtalmologie·P Massin
Jun 29, 2010·Lancet·Ning CheungTien Yin Wong
Nov 21, 2009·Acta Ophthalmologica·Elisabet Agardh
Aug 8, 2015·Biochimica Et Biophysica Acta·Renu A Kowluru, Manish Mishra
Jul 30, 2015·Journal of Diabetes Investigation·Timothy S Kern, Bruce A Berkowitz
May 16, 2015·Progress in Retinal and Eye Research·Renu A KowluruBinit Kumar
Aug 12, 2014·BioMed Research International·Sher Zaman SafiIkram Shah Bin Ismail
Apr 1, 2011·Saudi Journal of Ophthalmology : Official Journal of the Saudi Ophthalmological Society·Ahmed M Abu El-Asrar, Hani S Al-Mezaine
Jun 30, 2016·Journal of Drug Targeting·Suchitra Kumari PanigrahyAwanish Kumar
May 20, 2017·Pharmaceuticals·Marta RuiSimona Collina
May 2, 2009·Expert Opinion on Pharmacotherapy·Stephen G SchwartzIngrid U Scott
Apr 21, 2009·Lancet·Anna B Einarsdóttir, Einar Stefánsson
Dec 29, 2017·Indian Journal of Ophthalmology·Srilakshmi SrinivasanSindhu Murali
Aug 1, 2009·Current Opinion in Ophthalmology·Ahmed M Abu El-AsrarMohammad Shamsul Ola
Nov 26, 2009·Expert Opinion on Pharmacotherapy·Ronald P Danis, Matthew J Sheetz
Mar 29, 2013·The Journal of Pharmacology and Experimental Therapeutics·Kyoung In JungChan Kee Park
May 1, 2009·Nature Reviews. Drug Discovery·Nigel A CalcuttAnn Marie Schmidt
Jan 11, 2013·Physiological Reviews·Josephine M Forbes, Mark E Cooper
Dec 16, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Angeline Julius, Waheeta Hopper
Jun 4, 2021·Frontiers in Pharmacology·Bruna CaridiPatric Turowski
Dec 21, 2020·Canadian Journal of Diabetes·Amaranta Sarai ValdezGuerreroDiana Alemán-González-Duhart
Apr 16, 2010·Current Opinion in Ophthalmology

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.